Table 2.
Prevalence of genes encoding virulence determinants of MRSA and MSSA isolates among nasal carriage and clinical samples.
| Virulence genes | N (%) of isolates |
Total (N= 78) |
|
|---|---|---|---|
|
MSSA N=53 |
MRSA N=25 |
||
| hla | 52 (98) | 25 (100) | 77 (99) |
| pvl | 7 (13) | 10 (40) | 17 (22) |
| tst | 9 (17) | 4 (16) | 13 (17) |
| sea | 20 (38) | 14 (56) | 34 (44) |
| seb | 6 (11) | 7 (28) | 13 (17) |
| sec | 11 (21) | 5 (20) | 16 (21) |
| sed | 11 (21) | 9 (36) | 30 (38) |
| icaA | 39 (74) | 18 (72) | 57 (73) |
| icaD | 43 (81) | 16 (64) | 59 (76) |
| cna | 28 (53) | 19 (76) | 47 (60) |
| ebpS | 28 (53) | 11 (44) | 39 (50) |
| eno | 49 (92) | 25 (100) | 74 (95) |
| fib | 30 (57) | 20 (80) | 50 (64) |
| fnbA | 0 | 0 | 0 |
| fnbB | 11 (21) | 4 (16) | 15 (19) |